Patents by Inventor Heather Van Epps

Heather Van Epps has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260286011
    Abstract: The present disclosure provides antibodies or antigen-binding fragments thereof that are capable of binding to free drug of antibody drug conjugates (ADCs), and related technologies. The present disclosure also provides methods of treating or preventing off-target effects of ADCs in a subject that involve administering a therapeutically effective amount of a pharmaceutical composition comprising an antibody or antigen-binding fragment thereof provided herein to a subject.
    Type: Application
    Filed: December 15, 2025
    Publication date: September 24, 2026
    Inventors: Melissa Leith Conerly, Heather Van Epps, Erin C. Yang, Benjamin Manning, Peter Bloomingdale, Jiayu Chen, Hideki Shishido, Giovanni Tosi, Rounak Nassirpour, Monica Menzenski, Thomas William Linsky, Adambarage Dinesh De Alwis, Kapil Mayawala
  • Publication number: 20260242481
    Abstract: Provided are novel anti-PD-L1 antibodies and antibody-drug conjugates and methods of using such anti-PD-L1 antibodies and antibody-drug conjugates to treat cancer.
    Type: Application
    Filed: September 5, 2025
    Publication date: August 20, 2026
    Applicant: Seagen Inc.
    Inventors: Byron Hua KWAN, Heather VAN EPPS, Andrew WAIGHT, Scott JEFFREY, Ryan LYSKI
  • Publication number: 20260116963
    Abstract: The present application provides anti-IL-13 antibodies and antigen binding fragments thereof. Such antibodies and antigen binding fragments thereof may be used in methods for the treatment and/or prevention of an immunological disease or disorder.
    Type: Application
    Filed: January 3, 2025
    Publication date: April 30, 2026
    Inventors: Adam ROOT, Jaileene HERNANDEZ ESCALANTE, Nadine SHABAN, Monica MENZENSKI, Kristen JOHNSON, Brinda MONIAN, Todd ASHWORTH, Kapil MAYAWALA, Heather VAN EPPS, Tanvi Krishnakumar GAWDE, Vikram SADINENI
  • Patent number: 12421312
    Abstract: Provided are novel anti-PD-L1 antibodies and antibody-drug conjugates and methods of using such anti-PD-L1 antibodies and antibody-drug conjugates to treat cancer.
    Type: Grant
    Filed: October 2, 2020
    Date of Patent: September 23, 2025
    Assignee: Seagen Inc.
    Inventors: Byron Hua Kwan, Heather Van Epps, Andrew Waight, Scott Jeffrey, Ryan Lyski
  • Publication number: 20230270877
    Abstract: Provided herein are methods of treating cancer with an antibody that binds an immune cell engager in combination with an antibody-drug conjugate.
    Type: Application
    Filed: April 28, 2023
    Publication date: August 31, 2023
    Applicant: Seagen Inc.
    Inventors: Shyra Gardai, Alyson Smith, Kerry Klussman, Bernard Liu, Heather Van Epps
  • Publication number: 20230118517
    Abstract: Provided herein are methods of treating multiple myeloma (MM) using specific doses of an anti-B-cell migration antigen (BCMA) antibody, various dosing regimens, and optionally combination therapy with dexamethasone, an immunomodulatory agent (e.g., pomalinamide), an anti-CD38 antibody or antigen binding fragment thereof (e.g., daratumumab), and a gamma secretase inhibitor (GSI), and/or various combinations thereof.
    Type: Application
    Filed: March 25, 2021
    Publication date: April 20, 2023
    Inventors: Mary Campbell, Heather Van Epps, Haley Neff-LaFord, Celine Fabienne Jacquemont, David Taft, Hong Li
  • Publication number: 20210101982
    Abstract: Provided are novel anti-PD-L1 antibodies and antibody-drug conjugates and methods of using such anti-PD-L1 antibodies and antibody-drug conjugates to treat cancer.
    Type: Application
    Filed: October 2, 2020
    Publication date: April 8, 2021
    Inventors: Byron Hua Kwan, Heather Van Epps, Andrew Waight